Organization
Warszawa, Poland
3 abstracts
Abstract
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.Org: Oncology Institute of Southern Switzerland, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland, University of Southampton,
Abstract
Safety, pharmacokinetics and anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with locally advanced or metastatic solid tumors.Org: Jagiellonian University Hospital, Kraków, Poland, Kraków University Hospital, Krakow, Poland, Polish Mother's Memorial Hospital - Research Institute,
Abstract
Standardizing the strategy in glioblastoma trials to promote success in cell and gene therapy clinical development.Org: Parexel, Stockholm School of Economics Institute for Research, Stockholm, Sweden, Sweden, Parexel Intl, Durham Veteran Affairs Medical Center,